EUVIMEDEUVIMED entdecken
Crossref

KuiAnNingFang alleviates ulcerative colitis by modulating gut microbiota and NF-κB/NLRP3 pathway

Chunli Sun, Yuehuan Tian, Yitan Zheng, Kunrong Yang, Shengnan Liu, Danrong Zhao, Linyi Li, Xiaohui Yin, Hui Li, Jinyou Duan, Haibo Mu, Qianjin Liu und 1 weitere

Phytomedicine · 2026

DOI: 10.1016/j.phymed.2025.157677 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Chunli Sun und 12 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, Ji…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Gastrointestinal Microbiome, NF-kappa B, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Kunming Medical University, Xuzhou Medical University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ulcerative colitis (UC), a major form of inflammatory bowel disease, is a chronic and relapsing inflammatory condition of the colonic mucosa. Despite the efficacy of the Traditional Chinese Medicine formula KuiAnNingFang (KANF) in alleviating UC, its therapeutic mechanisms remain incompletely understood. PURPOSE: This study aimed to elucidate the ameliorative effect of Chinese medicine KANF and its potential mechanism against UC. METHODS: The therapeutic efficacy of KANF against UC was initially assessed in clinical cohorts. A murine model of UC was subsequently established by administering DSS in drinking water and oral treatment with KANF extracts. The prototype components of KANF absorbed into the bloodstream were identified using UPLC-MS/MS. RNA-seq was conducted to identify differentially expressed genes and altered signaling pathways in colonic tissue. Furthermore, 16S rDNA sequencing and fecal microbiota transplantation were employed to determine whether KANF ameliorates UC by modulating the gut microbiota. RESULTS: KANF demonstrated significant therapeutic efficacy in alleviating UC in both clinical patients and animal models. Integrated analysis combining network pharmacology and RNA-seq validated that KANF attenuates intestinal inflammation by inhibiting NF-κB/NLRP3 activation. Furthermore, 16S rDNA sequencing revealed that KANF restores gut microbial homeostasis, and fecal microbiota transplantation experiments confirmed that the suppressive effect of KANF on NF-κB/NLRP3 signaling is primarily mediated through gut microbiota remodeling. CONCLUSION: KANF can significantly ameliorate symptoms in both clinical UC patients and DSS-induced colitis mice. KANF exerts its multi-target anti-colitic effects through regulation of the gut microbiota and subsequent suppression of the NF-κB/NLRP3 signaling cascade.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeGastrointestinal MicrobiomeNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinDrugs, Chinese HerbalAnimalsMiceHumansMaleSignal TransductionMice, Inbred C57BLDisease Models, AnimalFemaleFecal Microbiota TransplantationDextran SulfateMiddle AgedAdult

Stichwörter der Autor:innen

Fecal microbiota transplantationGut microbiotaKuiAnNingFangNLRP3 inflammasomeUlcerative colitis

Substanzen

NF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinDrugs, Chinese HerbalNlrp3 protein, mouseDextran Sulfate

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China.
  • Department of Traditional Chinese Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, China, Kunming Medical University, Kunming, 650000, China.
  • College of Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China.
  • Department of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, China, Kunming Medical University, Kunming, China; Yunnan Province Clinical Research Center for Digestive Diseases, K…
  • College of Chemistry & Pharmacy, Shaanxi Key Laboratory of Natural Products & Chemical Biology, Northwest A&F University, Yangling, Shaanxi, 712100, China.
  • College of Chemistry & Pharmacy, Shaanxi Key Laboratory of Natural Products & Chemical Biology, Northwest A&F University, Yangling, Shaanxi, 712100, China. Electronic address: mhb1025@nwafu.edu.cn.

Förderung

  • Kunming Medical University
  • Xuzhou Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Sun, C., Tian, Y., Zheng, Y., Yang, K., Liu, S., Zhao, D., Li, L., Yin, X., Li, H., Duan, J., Mu, H., Liu, Q., & Luo, J. (2026). KuiAnNingFang alleviates ulcerative colitis by modulating gut microbiota and NF-κB/NLRP3 pathway. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157677

Vancouver

Sun C, Tian Y, Zheng Y, Yang K, Liu S, Zhao D, et al. KuiAnNingFang alleviates ulcerative colitis by modulating gut microbiota and NF-κB/NLRP3 pathway. Phytomedicine. 2026. doi:10.1016/j.phymed.2025.157677

BibTeX
@article{Sun2026,
  author = {Sun, Chunli and Tian, Yuehuan and Zheng, Yitan and Yang, Kunrong and Liu, Shengnan and Zhao, Danrong and Li, Linyi and Yin, Xiaohui and Li, Hui and Duan, Jinyou and Mu, Haibo and Liu, Qianjin and Luo, Juan},
  title = {KuiAnNingFang alleviates ulcerative colitis by modulating gut microbiota and NF-κB/NLRP3 pathway},
  journal = {Phytomedicine},
  year = {2026},
  doi = {10.1016/j.phymed.2025.157677}
}
Kostenlos starten →